SYNT001

SYNT001 · Alexion Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SYNT001, covering 2020-02-05 to 2020-05-13. Get the full timeline:

Most recent: Clinical Trial Update: A Safety Study of SYNT001 in Participants With Warm Autoimmune Hemolytic Anemia (WAIHA) [Phase 1, Phase 2]